Business of Biotech Series: Synthetic Biology

Business of Biotech Series - Synthetic Biology with DNA2.0 by Madhuri Ganta

Please join me for the latest installment of the Business of Biotech series from DNA2.0's Madhuri Ganta. Madhuri will discuss research on codon optimization to improve gene expression, protein variant library synthesis and protein engineering strategies.

Founded in 2003, DNA2.0 provides an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries.

DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. The company is privately held and is headquartered in Menlo Park, Calif.